Amneal Pharmaceuticals (STU:2DT) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:2DT Amneal Pharmaceuticals Inc STU:2DT
65 GF Score
Price €16.20
GF Value €7.11
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Amneal Pharmaceuticals Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Amneal Pharmaceuticals  (STU:2DT) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Amneal Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms


Amneal Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Amneal Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amneal Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Amneal Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.62 0.28 0.98 1.70 4.16

Amneal Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.45 1.94 2.84 3.17 5.10

STU:2DT vs KNSA, LQDA, LNTH: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Amneal Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amneal Pharmaceuticals Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amneal Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Amneal Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


STU:2DT
65GF Score
Amneal Pharmaceuticals Inc STU:2DT
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amneal Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Amneal Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Amneal Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.32/333.9520*333.9520
=0.320

Current CPI (Jun. 2026) = 333.9520.

Amneal Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201609 10.879 241.428 15.048
201612 8.026 241.432 11.102
201703 6.852 243.801 9.386
201706 244.955 0.000
201709 246.819 0.000
201712 -1.655 246.524 -2.242
201803 0.008 249.554 0.011
201806 6.406 251.989 8.490
201809 6.190 252.439 8.189
201812 6.156 251.233 8.183
201903 5.569 254.202 7.316
201906 5.135 256.143 6.695
201909 2.707 256.759 3.521
201912 2.101 256.974 2.730
202003 2.574 258.115 3.330
202006 2.314 257.797 2.998
202009 2.081 260.280 2.670
202012 1.974 260.474 2.531
202103 2.173 264.877 2.740
202106 2.285 271.696 2.809
202109 2.302 274.310 2.803
202112 2.259 278.802 2.706
202203 2.526 287.504 2.934
202206 1.208 296.311 1.361
202209 1.461 296.808 1.644
202212 1.292 296.797 1.454
202303 0.974 301.836 1.078
202306 1.088 305.109 1.191
202309 1.171 307.789 1.271
202312 0.181 306.746 0.197
202403 -0.050 312.332 -0.053
202406 -0.012 314.175 -0.013
202409 -0.097 315.301 -0.103
202412 -0.139 315.605 -0.147
202503 -0.175 319.799 -0.183
202506 -0.127 322.561 -0.131
202509 -0.114 324.800 -0.117
202512 0.016 324.054 0.016
202603 0.109 330.213 0.110
202606 0.320 333.952 0.320

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Amneal Pharmaceuticals (STU:2DT) Overvalued in 2026?

Based on GuruFocus' analysis, Amneal Pharmaceuticals stock appears to be overvalued. The current stock price of €16.20 is trading 127.8% above its estimated GF Value™ of €7.11. GuruFocus considers Amneal Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for STU:2DT:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €7.11 vs. price of €16.20 (127.8% above fair value)
  • GF Score™: 65/100 with 7 warning signs

No single metric tells the full story. See the STU:2DT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Amneal Pharmaceuticals Business Description

Other Exchanges AMRX:USA
Address 400 Crossing Boulevard, 3rd Floor, Bridgewater, NJ, USA, 08807
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
65GF Score

Get the complete analysis for STU:2DT

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.20
Price
€7.11
GF Value